109882-31-7

Basic information

• Product Name: 5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid methyl ester
• Synonyms: 5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid methyl ester
• CAS NO: 109882-31-7
• Molecular Formula: C17H25N3O4
• Molecular Weight: 335
• Mol File: 109882-31-7.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 573.6±50.0 °C(Predicted)
• Appearance: /
• Density: 1.23
• PKA: 14.26±0.10(Predicted)
• CAS DataBase Reference: 5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid methyl ester(109882-31-7)
• EPA Substance Registry System: 5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid methyl ester(109882-31-7)

Safety Data

• Hazardous Substances Data: 109882-31-7(Hazardous Substances Data)

Usage

General Description

The chemical 5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid methyl ester is a complex compound with multiple functional groups. It contains a benzimidazole ring with a methyl and carboxylic acid groups attached to it. Additionally, it has two hydroxyethylamine groups and a butanoic acid ester. This chemical is likely to have biological activity due to the presence of the benzimidazole ring, which is known to have pharmaceutical properties. The presence of the hydroxyethylamine groups also suggests potential interactions with biological systems, possibly as a chelator or enzyme inhibitor. Overall, the complex structure of this chemical indicates potential pharmaceutical or biological applications.

Upstream product

• 2784-94-3 4-bis(2'-hydroxy-ethyl)amino-1-methyl-amino-2-nitro-benzene 
• 29705-38-2 2,2'-[(4-fluoro-3-nitrophenyl)imino]bisethanol 
• 67-56-1 methanol 
• 1464999-05-0 C₁₆H₂₅N₃O₅ 
• 3543-75-7 bendamustine hydrochloride 
• 109882-29-3 4-<1-Methyl-5-benzimidazolyl-(2)>butansaeure-hydrochlorid 
• 186581-53-3 diazomethane 
• 109882-30-6 4-<1-Methyl-5-benzimidazolyl-(2)>butansaeure 

Downstream Products

• 3543-75-7 bendamustine hydrochloride 
• 109882-25-9 4-{5-[bis-(2-chloro-ethyl)amino]-1-methyl-1H-benzoimidazol-2-yl}butyric acid methyl ester 

Relevant articles and documents

PROCESS FOR MAKING BENDAMUSTINE

The invention deals with a novel process, and intermediates for making the pharmaceutically useful product bendamustine of formula (1), or a pharmaceutically acceptable salt thereof, said process inter alia being based on using the compound of formula (13) as the starting material.